Meridian Bioscience reported $56.46M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Abbott ABT:US $ 12647M 458M
Accelerate Diagnostics AXDX:US 8.21M 1.27M
Atrion ATRI:US 13.35M 1.47M
Becton, Dickinson and BDX:US $ 6657M 78M
Bio Rad Laboratories BIO:US $ 648.33M 32.61M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Cerus CERS:US $ 66.66M 11.9M
Meridian Bioscience VIVO:US $ 56.46M 6.52M
Myriad Genetics MYGN:US $ 166M 38.3M
Orasure Technologies OSUR:US $ 55.59M 12.48M
Quidel QDEL:US $ 492.66M 169.14M
Sientra SIEN:US $ 84.65M 4.63M
Staar Surgical STAA:US $ 41.18M 7.62M
Thermo Fisher Scientific TMO:US $ 12070M 1366M
Utah Medical Products UTMD:US $ 5.01M 448K